Andrew McConaghie

@awmcconaghie

Senior Writer, Scrip. Pharma and healthcare updates

Europe
Vrijeme pridruživanja: veljača 2014.

Tweetovi

Blokirali ste korisnika/cu @awmcconaghie

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @awmcconaghie

  1. Poništi
  2. proslijedio/la je Tweet

    All rise: The new edition of Private Eye is out now.

    Poništi
  3. proslijedio/la je Tweet
    31. sij

    Brexit Finally Here But Uncertainty Not Over For Biopharma

    Poništi
  4. proslijedio/la je Tweet

    Nigel Farage has just unveiled a portrait of himself entitled "Mr Brexit". Jim Davidson is now giving a speech to mark the occasion. Happy Brexit everyone

    Prikaži ovu nit
    Poništi
  5. 24. sij

    An interesting test case in the problems of using real world data in the, er, real world.

    Poništi
  6. 23. sij

    UK funding held up in 2019, despite Woodford and Brexit. Expect IPOs to stay thin on the ground in 2020. Speedy clinical progress still paramount for IO, gene and cell therapy start-ups

    Poništi
  7. 22. sij

    Once an industry pariah thanks to price-gouging on old medicines, Horizon begins its reinvention with US approval of first treatment for thyroid eye disease

    Poništi
  8. proslijedio/la je Tweet
    21. sij

    Here's a pic of me and some friends reenacting the 15th Ludhiana Sikhs with . They were sent to the WESTERN Front and fought alongside British soldiers! and other commonwealth soldiers gave their lives for you to have your freedoms now.

    Poništi
  9. proslijedio/la je Tweet
    17. sij

    Two boys decide to prank their grandmother by meeting her at the airport dressed as dinosaurs. Grandma heard about it and decided to prank them first. Maybe the greatest prank ever!

    Poništi
  10. 21. sij

    Biopharma CEOs join debates on future of science, business and society - though whether they can influence US and Chinese leaders on healthcare policy is another matter

    Poništi
  11. 15. sij

    Vas Narasimhan gets biggest laugh in exchange with 's Francesco De Rubertis who asks 3 CEOs to name their next M&A targets. Vas jokes: I've a question for you: do you feel biotech evaluation expectations have got completely out of hand?!

    Poništi
  12. proslijedio/la je Tweet
    14. sij

    Good morning & welcome to Day 2! Here’s a Day 1 recap from me, & available for free without a subscription to & . Watch for more presentation and interview highlights in the coming days.

    Poništi
  13. 13. sij

    What a lovely way to warm up for , and what great company. Though we need to hire somebody from a fourth continent with long arms to take the selfie.

    Poništi
  14. 12. sij

    A great article by my colleague Brian Yang on the explosive growth in China biopharma, including first China-developed drugs gaining US approval. Lots of Chinese companies here at and in San Francisco

    Poništi
  15. 9. sij

    The excellent on the annual ramping up of investor expectation ahead of

    Poništi
  16. 9. sij

    Alnylam's alliance with Regeneron could help it unlock the full potential of its RNAi tech - but Ionis has the lead in CNS therapies such as Huntington's

    Poništi
  17. 6. sij
    Poništi
  18. 2. sij

    The year ahead almost certain to see more gene therapy companies snapped up. AbbVie and Takeda expected to extend their 2019 buying sprees into the new year. &a

    Poništi
  19. 31. pro 2019.
    Poništi
  20. proslijedio/la je Tweet

    I think everyone at ITV, C4 and elsewhere should be very careful about feeling good about this. It may not be that we are doing anything different, nor that the BBC are doing anything different, but just that the attacks on us haven’t started yet.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·